Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199
about
Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problemGuidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaAntibiotic-Resistant Acinetobacter baumannii Increasing Success Remains a Challenge as a Nosocomial PathogenUpdate on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic optionsInfection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for InstitutesStenotrophomonas maltophilia: an emerging global opportunistic pathogenMultidrug-resistant Acinetobacter baumanniiEffects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilmSecular trends of antimicrobial resistance of blood isolates in a newly founded Greek hospital.Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study.Cotrimoxazole - optimal dosing in the critically ill.Emergence of Stenotrophomonas maltophilia nosocomial isolates in a Saudi children's hospital. Risk factors and clinical characteristicsCharacterization of bacterial contaminants in the air of a duck hatchery by cultivation based and molecular methods.Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation.Sequence-based typing of ade B as a potential tool to identify intraspecific groups among clinical strains of multidrug-resistant Acinetobacter baumannii.Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species.Gram-negative infections in adult intensive care units of latin america and the CaribbeanSurveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001Phenotypic and molecular characterization of Acinetobacter clinical isolates obtained from inmates of California correctional facilitiesInsect-derived cecropins display activity against Acinetobacter baumannii in a whole-animal high-throughput Caenorhabditis elegans modelHospital acquired antibiotic-resistant acinetobacter baumannii infections in a 400-bed hospital in Tehran, Iran.Antibiogram of Stenotrophomonas maltophilia Isolated From Nkonkobe Municipality, Eastern Cape Province, South Africa.Nonfermenting gram-negative bacilli infections in a tertiary care hospital in kolar, karnatakaThe molecular epidemiology of Stenotrophomonas maltophilia bacteraemia in a tertiary referral hospital in the United Arab Emirates 2000-2004Antibiofilm Activity of the Brown Alga Halidrys siliquosa against Clinically Relevant Human PathogensVEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.Toll-Like Receptor 9 Contributes to Defense against Acinetobacter baumannii Infection.Dental plaque bacteria with reduced susceptibility to chlorhexidine are multidrug resistantCombination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients.High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital.Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: Molecular and drug susceptibility profiles.Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.Pathogenic analysis of sputum from ventilator-associated pneumonia in a pediatric intensive care unitAntimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?Changes in gram negative microorganisms' resistance pattern during 4 years period in a referral teaching hospital; a surveillance study
P2860
Q21245789-08168824-BF11-4A03-B319-DAB82F56F3A8Q22241905-2EE6934B-4693-4F14-BD7C-8B59FF971AA9Q26766333-81804464-58D3-4344-BE7F-26C2C32F3C3AQ26782924-15C6EC5F-D213-4E8E-9A2E-F93A4035581EQ26799202-D7093FE7-5204-4A68-BD19-BDA65D79C1FEQ26995336-B687F5BE-9456-40A9-A78B-43188D821E36Q28306885-62EE9873-7E84-4C9E-9D29-1F36D2CF9F48Q28541755-128A97E1-FFEE-472E-94E8-1ACA0E5350D6Q33246842-82E2E5A4-C1C5-4421-BDCB-A743A67E396BQ33341476-BB4FDFD4-E1EC-4689-A4C6-E998A6DB09D9Q33652427-68FDF74B-E5BA-4EED-9097-B9C9613B3122Q33735341-A7D6719F-0B43-477B-95C8-AC38194E9B9EQ33775744-7D8EE0AD-9D15-4564-A1F9-255107E65463Q33892585-093303A5-9C57-41CB-9010-51C700F17B66Q34073492-FB6EE837-3F08-4CBB-87A8-76E5A2DF3D8CQ34128899-833A74C3-78C6-451E-B15E-09B16EF8D21DQ34466373-A65AE19C-E679-4408-B746-14C1D0227D49Q34695842-929A5FF3-B337-4823-AC22-2A7766BB4AF0Q34941008-629C4E0B-54AE-4362-ADAF-0C9AD2B209B6Q35066715-FD7883AB-8A6A-4934-85D0-8C04AE94324AQ35076900-0BF5BF89-1616-418D-A1AC-07438EB4567FQ35127885-AE0E09A1-26AF-45AB-90A6-CFA98463A384Q35148622-8831481E-38BF-4718-9444-0C5C3D2C65CAQ35199329-65EA4F13-757D-4FDD-9CBB-25E10E517B5CQ35597556-F3214FD5-2A94-4A06-BC9B-48F95F250B6FQ35658468-5582C20A-E05C-4DB1-84ED-F82215630520Q35793194-4F665F3A-1843-479D-973E-B3F4613E089DQ35848861-C5814B96-BAEA-4CDE-AED3-24386066157DQ36053482-AB8DFCFF-48AF-4CC8-AEDC-9B7500ADFE9FQ36133394-4C3BFD46-515C-4FE0-B0D5-A23DE8ED13C0Q36171630-FC718344-52B3-4065-99A7-E55199EEB4ABQ36239995-50602032-16E7-49D5-A667-9AD716B81882Q36322117-AEF284F4-1BD0-4A10-A1BF-63D288F8CAD1Q36364166-CC5985D4-332E-4B3C-B2ED-AB49569648CFQ36382134-8964AD29-A4A9-4021-BB85-E4DCFA2AD0EDQ36406755-DEA5D23E-BC48-4B1D-A395-B3A30290EA43Q36472408-71423112-ECB9-459D-B94D-1DF94E3D4D58Q36536350-B438B0B4-D716-490F-BB41-2246E65D07C9Q36559365-209F7DA5-FB2C-4DEC-827E-987DCA28B853Q36564502-886849A3-0D9F-4513-A175-9B553CA6E3A9
P2860
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Emerging importance of multidr ...... bial Surveillance Program (199
@en
Emerging importance of multidr ...... bial Surveillance Program (199
@nl
type
label
Emerging importance of multidr ...... bial Surveillance Program (199
@en
Emerging importance of multidr ...... bial Surveillance Program (199
@nl
prefLabel
Emerging importance of multidr ...... bial Surveillance Program (199
@en
Emerging importance of multidr ...... bial Surveillance Program (199
@nl
P2093
P2860
P921
P356
P1476
Emerging importance of multidr ...... rveillance Program (1997-1999)
@en
P2093
P2860
P304
P356
10.1086/320183
P407
P478
32 Suppl 2
P50
P577
2001-05-01T00:00:00Z